MA
Montag & Associates Portfolio holdings
AUM
$2.05B
1-Year Return
15.52%
This Quarter Return
+4.73%
1 Year Return
+15.52%
3 Year Return
+68.32%
5 Year Return
+122.02%
10 Year Return
+298.03%
AUM
$613M
AUM Growth
+$21.7M
(+3.7%)
Cap. Flow
-$3.18M
Cap. Flow
% of AUM
-0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.48%
Holding
251
New
18
Increased
52
Reduced
87
Closed
9
Top Buys
| 1 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
$9.2M |
| 2 |
Gilead Sciences
GILD
|
$4.36M |
| 3 |
Eli Lilly
LLY
|
$3.17M |
| 4 |
Ingredion
INGR
|
$2.82M |
| 5 |
Cisco
CSCO
|
$2.73M |
Top Sells
| 1 |
CF Industries
CF
|
$4.8M |
| 2 |
Weyerhaeuser
WY
|
$4.32M |
| 3 |
Omnicom Group
OMC
|
$3.81M |
| 4 |
Huntington Ingalls Industries
HII
|
$3.76M |
| 5 |
MCRS
MICROS SYSTEMS INC
MCRS
|
$2.73M |
Sector Composition
| 1 | Healthcare | 12.05% |
| 2 | Financials | 10.79% |
| 3 | Industrials | 8.97% |
| 4 | Consumer Staples | 8.89% |
| 5 | Technology | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Invesco S&P 500 Equal Weight ETF
RSP
$74.1B
| $5.86M | 0.96% |
76,439
-24,375
| -24% | -$1.87M |
|
27
Exxon Mobil
XOM
$466B
| $5.84M | 0.95% |
58,043
+2,551
| +5% | +$257K |
|
|
STI
28
DELISTED
SunTrust Banks, Inc.
STI
| $5.65M | 0.92% |
141,006
+20,019
| +17% | +$802K |
|
29
Apple
AAPL
$3.56T
| $5.6M | 0.91% |
241,208
-8,580
| -3% | -$199K |
|
30
Boeing
BA
$174B
| $5.57M | 0.91% |
43,789
+2,510
| +6% | +$319K |
|
31
Edwards Lifesciences
EW
$47.5B
| $5.55M | 0.9% |
387,786
+148,290
| +62% | +$2.12M |
|
32
Pfizer
PFE
$141B
| $5.52M | 0.9% |
195,874
-68,630
| -26% | -$1.93M |
|
33
Diageo
DEO
$61.3B
| $5.5M | 0.9% |
43,183
-10
| -0% | -$1.27K |
|
34
Citigroup
C
$176B
| $5.41M | 0.88% |
114,848
-6,237
| -5% | -$294K |
|
35
Masco
MAS
$15.9B
| $5.3M | 0.86% |
271,413
+40,877
| +18% | +$797K |
|
36
Chevron
CVX
$310B
| $5.23M | 0.85% |
40,020
+242
| +0.6% | +$31.6K |
|
37
Schlumberger
SLB
$53.4B
| $5.17M | 0.84% |
43,807
+156
| +0.4% | +$18.4K |
|
38
CVS Health
CVS
$93.6B
| $4.84M | 0.79% |
64,218
-1,170
| -2% | -$88.2K |
|
39
Markel Group
MKL
$24.2B
| $4.67M | 0.76% |
7,126
+504
| +8% | +$330K |
|
40
Wells Fargo
WFC
$253B
| $4.59M | 0.75% |
87,239
-1,594
| -2% | -$83.8K |
|
41
Martin Marietta Materials
MLM
$37.5B
| $4.58M | 0.75% |
34,715
+4,030
| +13% | +$532K |
|
|
42
Gilead Sciences
GILD
$143B
| $4.36M | 0.71% |
+52,627
| New | +$4.36M |
|
43
PepsiCo
PEP
$200B
| $4.35M | 0.71% |
48,648
-197
| -0.4% | -$17.6K |
|
44
Merck
MRK
$212B
| $4.14M | 0.67% |
74,946
-83
| -0.1% | -$4.58K |
|
45
Crane NXT
CXT
$3.51B
| $4.12M | 0.67% |
159,353
-4,606
| -3% | -$119K |
|
46
Fiserv
FI
$73.4B
| $3.98M | 0.65% |
131,852
| – | – |
|
|
ESL
47
DELISTED
Esterline Technologies
ESL
| $3.93M | 0.64% |
34,150
+3,365
| +11% | +$387K |
|
48
Willis Towers Watson
WTW
$32.1B
| $3.89M | 0.63% |
33,918
-1,831
| -5% | -$210K |
|
49
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $3.81M | 0.62% |
89,420
-21,030
| -19% | -$896K |
|
50
Novartis
NVS
$251B
| $3.77M | 0.61% |
46,464
-2,153
| -4% | -$175K |
|